Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up

Stratigos, A.J.; Sekulic, A.; Peris, K.; Bechter, O.; Prey, S.; Lewis, K.D.; Basset-Seguin, N.; Chang, A.L.S.; Dalle, S.; Fernandez Orland, A.; Licitra, L.; Robert, C.; Ulrich, C.; Hauschild, A.; Migden, M.R.; Dummer, R.; Yoo, S.-.; Okoye, E.; Bassukas, I.; Loquai, C.; De Giorgi, V.; Eroglu, Z.; Gutzmer, R.; Ulrich, J.; Puig, S.; Inocencio, T.J.; Chen, C.-.; Lafontaine, P.R.; Seebach, F.; Lowy, I.; Fury, M.G.

doi:10.1016/j.jaad.2023.08.111

Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up / A.J. Stratigos, A. Sekulic, K. Peris, O. Bechter, S. Prey, K.D. Lewis, N. Basset-Seguin, A.L.S. Chang, S. Dalle, A. Fernandez Orland, L. Licitra, C. Robert, C. Ulrich, A. Hauschild, M.R. Migden, R. Dummer, S.-. Yoo, E. Okoye, I. Bassukas, C. Loquai, V. De Giorgi, Z. Eroglu, R. Gutzmer, J. Ulrich, S. Puig, T.J. Inocencio, C.-. Chen, P.R. Lafontaine, F. Seebach, I. Lowy, M.G. Fury. - In: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. - ISSN 0190-9622. - 90:2(2024 Feb), pp. 414-418. [10.1016/j.jaad.2023.08.111]